Ipca Laboratories’ wholly owned subsidiary -- Ipca Pharmaceuticals, Inc., USA has acquired further 20% share capital of Bayshore Pharmaceuticals LLC (Bayshore), a New Jersey limited liability company for $1.2 million. With this acquisition, Bayshore is now wholly owned by Ipca Pharmaceuitcals, Inc.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in many countries and its export accounts for around half of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates.
